ClouDr Group Ltd

HKSE:09955 (China)  
HK$ 2.64 (-1.86%) Jun 5
At Loss
P/B:
0.78
Market Cap:
HK$ 1.55B ($ 198.46M)
Enterprise V:
HK$ 1.22B ($ 156.06M)
Volume:
20.83M
Avg Vol (2M):
15.90M
Also Trade In:
Volume:
20.83M
At Loss
Avg Vol (2M):
15.90M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for ClouDr Group Ltd ( ) from 2022 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. ClouDr Group stock (HKSE:09955) PE ratio as of Jun 05 2024 is 0. More Details

ClouDr Group Ltd (HKSE:09955) PE Ratio (TTM) Chart

To

ClouDr Group Ltd (HKSE:09955) PE Ratio (TTM) Historical Data

Total 473
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
ClouDr Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-05 At Loss 2024-03-27 At Loss
2024-06-04 At Loss 2024-03-26 At Loss
2024-06-03 At Loss 2024-03-25 At Loss
2024-05-31 At Loss 2024-03-22 At Loss
2024-05-30 At Loss 2024-03-21 At Loss
2024-05-29 At Loss 2024-03-20 At Loss
2024-05-28 At Loss 2024-03-19 At Loss
2024-05-27 At Loss 2024-03-18 At Loss
2024-05-24 At Loss 2024-03-15 At Loss
2024-05-23 At Loss 2024-03-14 At Loss
2024-05-22 At Loss 2024-03-13 At Loss
2024-05-21 At Loss 2024-03-12 At Loss
2024-05-20 At Loss 2024-03-11 At Loss
2024-05-17 At Loss 2024-03-08 At Loss
2024-05-16 At Loss 2024-03-07 At Loss
2024-05-14 At Loss 2024-03-06 At Loss
2024-05-13 At Loss 2024-03-05 At Loss
2024-05-10 At Loss 2024-03-04 At Loss
2024-05-09 At Loss 2024-03-01 At Loss
2024-05-08 At Loss 2024-02-29 At Loss
2024-05-07 At Loss 2024-02-28 At Loss
2024-05-06 At Loss 2024-02-27 At Loss
2024-05-03 At Loss 2024-02-26 At Loss
2024-05-02 At Loss 2024-02-23 At Loss
2024-04-30 At Loss 2024-02-22 At Loss
2024-04-29 At Loss 2024-02-21 At Loss
2024-04-26 At Loss 2024-02-20 At Loss
2024-04-25 At Loss 2024-02-19 At Loss
2024-04-24 At Loss 2024-02-16 At Loss
2024-04-23 At Loss 2024-02-15 At Loss
2024-04-22 At Loss 2024-02-14 At Loss
2024-04-19 At Loss 2024-02-09 At Loss
2024-04-18 At Loss 2024-02-08 At Loss
2024-04-17 At Loss 2024-02-07 At Loss
2024-04-16 At Loss 2024-02-06 At Loss
2024-04-15 At Loss 2024-02-05 At Loss
2024-04-12 At Loss 2024-02-02 At Loss
2024-04-11 At Loss 2024-02-01 At Loss
2024-04-10 At Loss 2024-01-31 At Loss
2024-04-09 At Loss 2024-01-30 At Loss
2024-04-08 At Loss 2024-01-29 At Loss
2024-04-05 At Loss 2024-01-26 At Loss
2024-04-03 At Loss 2024-01-25 At Loss
2024-04-02 At Loss 2024-01-24 At Loss
2024-03-28 At Loss 2024-01-23 At Loss

ClouDr Group Ltd (HKSE:09955) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its segments include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.